Net profit of Jyothy Labs declined 2.38% to Rs 76.30 crore in the quarter ended March 2025 as against Rs 78.16 crore during the previous quarter ended March 2024. Sales rose 1.06% to Rs 666.96 crore in the quarter ended March 2025 as against Rs 659.99 crore during the previous quarter ended March 2024.For the full year,net profit rose 0.27% to Rs 370.43 crore in the year ended March 2025 as against Rs 369.45 crore during the previous year ended March 2024. Sales rose 3.27% to Rs 2846.98 crore in the year ended March 2025 as against Rs 2756.93 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales666.96659.99 1 2846.982756.93 3 OPM %16.7816.42 -17.5517.40 - PBDT125.76120.09 5 549.24528.80 4 PBT111.21107.23 4 493.11478.84 3 NP76.3078.16 -2 370.43369.45 0 Powered by Capital Market - Live News

Jyothy Labs announced that the Board of Directors of the Company at its meeting held on 12 May 2025, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 350%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Jyothy Labs will hold a meeting of the Board of Directors of the Company on 12 May 2025.Powered by Capital Market - Live News

Net profit of Jyothy Labs declined 3.83% to Rs 87.41 crore in the quarter ended December 2024 as against Rs 90.89 crore during the previous quarter ended December 2023. Sales rose 3.98% to Rs 704.45 crore in the quarter ended December 2024 as against Rs 677.50 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales704.45677.50 4 OPM %16.4317.51 - PBDT128.12128.03 0 PBT113.84115.20 -1 NP87.4190.89 -4 Powered by Capital Market - Live News

Jyothy Labs has launched a new product `Jovia` under its Personal Care category and `Maxo Anti-Mosquito Racquet` under its Household Insecticide Category. Powered by Capital Market - Live News